About Fuse Oncology
Fuse Oncology is a private company based in Greensboro, North Carolina, incorporated in 2021 in Delaware. It has reported $11,810,474 raised in two offerings on Form D since May 2022. Its chief executive is James Bauler.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 6, 2023 | Apr 21, 2023 | $8,859,474of $9.6M target | 20 | $442K | EquityRule 506(b) | Form D ↗ |
| Nov 4, 2021 | May 27, 2022 | $2,951,000fully sold | 18 | $163K | OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $11,810,474 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Fuse Oncology's Form D filed Apr 21, 2023.
JM
John Miller
Director
JB
Jay Brennan
Director
BS
Benjamin Sintay
Executive officer
JS
John Strider
Executive officer
JB
James Bauler
Chief Executive Officer and director
DW
David Wiant
Executive officer
Earlier filings also listed David Wiantt (executive officer, last listed May 2022).